Logo

Combination of obesity medication tirzepatide and menopause hormone therapy fuels weight loss

Combination of obesity medication tirzepatide and menopause hormone therapy fuels weight loss

Using tirzepatide and menopause hormone therapy at the same time leads to increased weight loss in postmenopausal women with overweight or obesity compared to use of tirzepatide treatment alone, according to a study being presented Saturday at ENDO 2025, the Endocrine Society's annual meeting in San Francisco, Calif.

👉 Full Story